Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Olanzapine
Treatment for Frontotemporal Dementia
Typical Dosage: 2.5-10mg daily
Effectiveness
70%
Safety Score
40%
Clinical Trials
15
Participants
800
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
40
DangerousModerateSafe
Treatment Details
Dosage Range
2.5-10mg daily
Time to Effect
Days to weeks
Treatment Duration
Short-term or lowest effective dose, long-term monitoring
Evidence Quality
MODERATENumber Needed to Treat (NNT)
6(Treat 6 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
20(Treat 20 patients to see 1 additional serious adverse event)
Confidence Score
55%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$75
Monitoring:$250
Side Effect Mgmt:$750
Total Annual:$1,075
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
POORQALYs Gained
0.05
Outcome-Based Costs
Cost per Responder
$1,791.67
Olanzapine Outcomes
for Frontotemporal Dementia
Efficacy Outcomes
Overall Effectiveness
+70%
Response Rate
+60%
Common Side Effects
Sedation
+30%
Weight gain
+20%
Metabolic changes
+15%
Extrapyramidal symptoms
+10%
Increased risk of stroke/TIA
+2%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov